This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Merz, W G Articles by Saral, R Search for Related Content PubMed PubMed Citation Articles by Merz, W G Articles by Saral, R

 Previous Article  |  Next Article 

J Clin Microbiol. 1986 October; 24(4): 581-584

Increased incidence of fungemia caused by Candida krusei.

ABSTRACT

Candida krusei colonized 12.4% of 868 patients undergoing episodes of therapy-induced granulocytopenia over a 9-year period. The gastrointestinal tract was most frequently colonized, followed by the respiratory tract and urinary tract. Ten patients developed systemic infections with C. krusei; all 10 had two or more positive blood cultures. Nine of the 10 patients were colonized with C. krusei, and 6 were receiving systemic antifungal agents at the time of development of the infection. Seven patients died within 1 month of C. krusei sepsis; systemic candidiasis was seen in the autopsies of the four patients on whom autopsies were performed. Therefore, C. krusei should be recognized as an emerging pathogen in select patient populations.

This article has been cited by other articles:

• Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Nagy, E., Dobiasova, S., Rinaldi, M., Barton, R., Veselov, A., the Global Antifungal Surveillance Group, (2008). Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46: 515-521 [Abstract] [Full Text]  
• Pfaller, M. A., Diekema, D. J. (2007). Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clin. Microbiol. Rev. 20: 133-163 [Abstract] [Full Text]  
• Lin, M. Y., Carmeli, Y., Zumsteg, J., Flores, E. L., Tolentino, J., Sreeramoju, P., Weber, S. G. (2005). Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study. Antimicrob. Agents Chemother. 49: 4555-4560 [Abstract] [Full Text]  
• Munoz, P., Sanchez-Somolinos, M., Alcala, L., Rodriguez-Creixems, M., Pelaez, T., Bouza, E. (2005). Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother 55: 188-193 [Abstract] [Full Text]  
• Sancak, B., Rex, J. H., Chen, E., Marr, K. (2004). Comparison of PCR- and HinfI Restriction Endonuclease-Based Methods for Typing of Candida krusei Isolates. J. Clin. Microbiol. 42: 5889-5891 [Abstract] [Full Text]  
• Arikan, S., Ostrosky-Zeichner, L., Lozano-Chiu, M., Paetznick, V., Gordon, D., Wallace, T., Rex, J. H. (2002). In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates. J. Clin. Microbiol. 40: 1406-1412 [Abstract] [Full Text]  
• Girmenia, C., Pagano, L., Leone, G., Martino, P., Bodey, G. P., Hanna, H. A., Raad, I. I. (2001). Fluconazole and Candida krusei Fungemia. Arch Intern Med 161: 2267-2269 [Full Text]  
• Abbas, J., Bodey, G. P., Hanna, H. A., Mardani, M., Girgawy, E., Abi-Said, D., Whimbey, E., Hachem, R., Raad, I. (2000). Candida krusei Fungemia: An Escalating Serious Infection in Immunocompromised Patients. Arch Intern Med 160: 2659-2664 [Abstract] [Full Text]  
• Kellogg, J. A., Bankert, D. A., Chaturvedi, V. (1999). Variation in Microbial Identification System Accuracy for Yeast Identification Depending on Commercial Source of Sabouraud Dextrose Agar. J. Clin. Microbiol. 37: 2080-2083 [Abstract] [Full Text]  
• Fidel, P. L. Jr., Vazquez, J. A., Sobel, J. D. (1999). Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans. Clin. Microbiol. Rev. 12: 80-96 [Abstract] [Full Text]  
• Kellogg, J. A., Bankert, D. A., Chaturvedi, V. (1998). Limitations of the Current Microbial Identification System for Identification of Clinical Yeast Isolates. J. Clin. Microbiol. 36: 1197-1200 [Abstract] [Full Text]  
• Vazquez, J. A., Dembry, L. M., Sanchez, V., Vazquez, M. A., Sobel, J. D., Dmuchowski, C., Zervos, M. J. (1998). Nosocomial Candida glabrata Colonization: an Epidemiologic Study. J. Clin. Microbiol. 36: 421-426 [Abstract] [Full Text]  
• Robert, R., Faure, O., Carloti, A., Lebeau, B., Bernard, C., Marot-Leblond, A., Grillot, R., Senet, J.-M. (1998). A Monoclonal Antibody Specific to Surface Antigen on Candida krusei. CVI 5: 121-124 [Abstract] [Full Text]